The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
The farnesoid X receptor (FXR) is a bile acid-regulated nuclear receptor expressed in enterohepatic tissues. In this study we investigated whether FXR is expressed by cells of innate immunity and regulates inflammation in animal models of colitis. Acute (7 days) and chronic (8 wk) colitis were induced in wild-type and FXR−/− mice by intrarectal administration of trinitrobenzensulfonic acid or by 7-day administration of 5% dextran sulfate in drinking water. The results of this experiment demonstrate that FXR is expressed by and exerts counterregulatory effects on cells of innate immunity. Exposure of LPS-activated macrophages to 6-ethyl chenodeoxycholic acid (6E-CDCA; INT-747) a synthetic FXR ligand, results in a reciprocal regulation of NF-κB dependent-genes (TNF-α, IL-1β, IL-6, COX-1, COX-2, and iNOS) and induction of SHP, a FXR-regulated gene. FXR activation stabilizes the nuclear corepressor NCoR on the NF-κB responsive element on the IL-1β promoter. Colon inflammation in Crohn’s disease patients and in rodent models of colitis is associated with a reduced expression of FXR mRNA. Using two rodent models of colon inflammation, we show that progression of these immune-mediated disorders is exacerbated in FXR−/− mice (p < 0.01). In vivo treatment with INT-747 attenuates organ injury and immune cell activation. FXR activation increased the colon expression of I-BABP, FXR, and SHP while reducing IL-1β, IL-2, IL-6, TNF-α, and IFN-γ mRNA expression and attenuating disease severity. In aggregate, these findings provide evidence that FXR is an essential component of a network of nuclear receptors that regulate intestinal innate immunity and homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXR is implicated in intestinal immunomodulation and barrier function (Vavassori et al., 2009).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Vavassori et al., 2009
In the citing paper
“An additional benefit of FXR activation in the intestine is based on intestinal immunity modulation and decreased ileal bacterial invasion.[80,81]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [80]
In the citing paper
“treatment with a synthetic agonist of BAR has protective effects in mouse models of colitis, whereas BAR-deficient (Nr1h4−/−) mice exhibit exacerbated pathology (Gadaleta et al., 2011; Vavassori et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Vavassori et al., 2009
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Cited by
Items 201–300 of 657
Zhang, H., Xie, Y., Cao, F., & Song, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2382336 · Cited by 77
Estrada, J. A., & Contreras, I. (2019) · Nutrients · doi:10.3390/nu11051076 · Cited by 66
Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD
Klepsch, V., Moschen, A. R., Tilg, H., Baier, G., & Hermann‐Kleiter, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01070 · Cited by 76
Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats
Ceulemans, L. J., Verbeke, L., Decuypere, J.-P., Farré, R., De Hertogh, G., Lenaerts, K., Jochmans, I., Monbaliu, D., Nevens, F., Tack, J., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169331 · Cited by 62
Giordano, C., Barone, I., Vircillo, V., Panza, S., Malivindi, R., Gelsomino, L., PELLEGRINO, M. A., Rago, V., Mauro, L., Lanzino, M., et al. (2016) · Scientific Reports · doi:10.1038/srep21782 · Cited by 63
Yang, F., Tang, X., Ding, L., Zhou, Y., Yang, Q., Gong, J., Wang, G., Wang, Z., & Yang, L. (2016) · Scientific Reports · doi:10.1038/srep33052 · Cited by 69
Haring, E., Uhl, F. M., Andrieux, G., Proietti, M., Bulashevska, A., Sauer, B., Braun, L. M., Gomez, E. D. V., Esser, P. R., Martin, S. F., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.242990 · Cited by 68
Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function
Ornelas, A., Dowdell, A. S., Lee, J. S., & Colgan, S. P. (2022) · Cells · doi:10.3390/cells11060944 · Cited by 75
Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats
Behr, C., Slopianka, M., Haake, V., Strauss, V., Sperber, S., Kamp, H., Walk, T., Beekmann, K., Rietjens, I. M. C. M., & van Ravenzwaay, B. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.012 · Cited by 58
Regulation of Gastrointestinal Immunity by Metabolites
Gu, B.-H., Kim, M., & Yun, C.-H. (2021) · Nutrients · doi:10.3390/nu13010167 · Cited by 58
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
Mullish, B. H., & Allegretti, J. R. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211017725 · Cited by 61
The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease
Suau, R., Pardina, E., Domènech, E., Lorén, V., & Manyé, J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab159 · Cited by 63
Gut Microbial Metabolites on Host Immune Responses in Health and Disease
Yoon, J.-H., Do, J.-S., Velankanni, P., Lee, C., & Kwon, H. (2023) · Immune Network · doi:10.4110/in.2023.23.e6 · Cited by 71
Roda, A., Pellicciari, R., Gioiello, A., Neri, F., Camborata, C., Passeri, D., Franco, F., Spinozzi, S., Colliva, C., Adorini, L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214650 · Cited by 65
Monaghan, T., Mullish, B. H., Patterson, J., Wong, G. K., Marchesi, J. R., Xu, H., Jilani, T., & Kao, D. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1506667 · Cited by 58
Vincenzo, F. D., Puca, P., Lopetuso, L. R., Petito, V., Masi, L., Bartocci, B., Murgiano, M., Felice, M. D., Petronio, L., Gasbarrini, A., et al. (2022) · Nutrients · doi:10.3390/nu14132664 · Cited by 64
Mencarelli, A., Distrutti, E., Renga, B., Cipriani, S., Palladino, G., Booth, C. E., Tudor, G. L., Guse, J., Hahn, U. K., Burnet, M. W. M., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.036 · Cited by 61
Self-citationFunctions of innate immune cells and commensal bacteria in gut homeostasis
Kayama, H., & Takeda, K. (2015) · The Journal of Biochemistry · doi:10.1093/jb/mvv119 · Cited by 65
Fiorucci, S., Zampella, A., Cirino, G., Bucci, M., & Distrutti, E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00577.2016 · Cited by 55
Self-citationLim, M. Y. C., & Ho, H. K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115985 · Cited by 66
Pregnane X Receptor Modulates the Inflammatory Response in Primary Cultures of Hepatocytes
Sun, M., Cui, W., Woody, S. K., & Staudinger, J. L. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062307 · Cited by 61
den Bossche, L. V., Borsboom, D., Devriese, S., Welden, S. V., Holvoet, T., Devisscher, L., Hindryckx, P., Vos, M. D., & Laukens, D. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.6 · Cited by 62
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 62
Alaish, S. M., Smith, A. D., Timmons, J., Greenspon, J., Eyvazzadeh, D., Murphy, E., Shea-Donahue, T., Cirimotich, S., Mongodin, E., Zhao, A., et al. (2013) · Gut Microbes · doi:10.4161/gmic.24706 · Cited by 54
Nouri‐Vaskeh, M., Mahdavi, A. M., Afshan, H., Alizadeh, L., & Zarei, M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6620 · Cited by 57
Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer
Chen, Y., & Chen, Y. (2021) · Cancers · doi:10.3390/cancers13164054 · Cited by 57
Hu, J., Zhang, Y., Yi, S., Wang, C., Huang, X., Pan, S., Yang, J., Yuan, G., Tan, S., & Li, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71287 · Cited by 58
Torres, J., Bao, X., Iuga, A. C., Chen, A., Harpaz, N., Ullman, T., Cohen, B. L., Pineton de Chambrun, G., Asciutti, S., Odin, J. A., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286ff2e · Cited by 53
The pathophysiological function of non-gastrointestinal farnesoid X receptor
Yan, N., Yan, T., Xia, Y., Hao, H., Wang, G., & Gonzalez, F. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107867 · Cited by 58
Attinkara, R., Mwinyi, J., Truninger, K., Regula, J., Gaj, P., Rogler, G., Kullak-Ublick, G. A., Eloranta, J. J., & The Swiss IBD Cohort Study Group (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-461 · Cited by 54
Bile acids: Key players in inflammatory bowel diseases?
Kriaa, A., Mariaule, V., Jablaoui, A., Rhimi, S., Mkaouar, H., Hernandez, J., Korkmaz, B., Lesner, A., Maguin, E., Aghdassi, A., et al. (2022) · Cells · doi:10.3390/cells11050901 · Cited by 53
“A reduced expression of FXR was identified in colonic endoscopic biopsies from patients with CD when compared with samples from individuals exhibiting irritable bowel syndrome [50].”
BackgroundResultGut Microbiota Co-microevolution with Selection for Host Humoral Immunity
Yang, L., Liu, S., Ding, J., Dai, R., He, C., Xu, K., Honaker, C. F., Zhang, Y., Siegel, P. B., & Meng, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01243 · Cited by 61
Renga, B., Mencarelli, A., Migliorati, M., Cipriani, S., D’Amore, C., Distrutti, E., & Fiorucci, S. (2011) · Inflammation Research · doi:10.1007/s00011-010-0306-1 · Cited by 53
Self-citationFan, Y., Xu, C., Xie, L., Wang, Y., Zhu, S., An, J., Li, Y., Tian, Z., Yan, Y., Yu, S., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.956528 · Cited by 56
Ciaula, A. D., Bonfrate, L., Khalil, M., & Portincasa, P. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03343-3 · Cited by 59
Ortuño‐Sahagún, D., Márquez-Aguirre, A. L., Quintero-Fabián, S., López-Roa, R. I., & Rojas-Mayorquín, A. E. (2012) · PPAR Research · doi:10.1155/2012/318613 · Cited by 65
Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
Li, L., Liu, T., Gu, Y., Wang, X., Xie, R., Sun, Y., Wang, B., & Cao, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974305 · Cited by 55
Du, J., Chen, Q., Li, Y., Xiang, X., Xu, W., Mai, K., & Ai, Q. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa185 · Cited by 51
Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention
Li, Q., & Chen, Y. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac659 · Cited by 53
Psyllium Fiber Protects Against Colitis Via Activation of Bile Acid Sensor Farnesoid X Receptor
Bretin, A., Zou, J., Yeoh, B. S., Ngo, V. L., Winer, S., Winer, D. A., Reddivari, L., Pellizzon, M., Walters, W. A., Patterson, A. D., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.007 · Cited by 55
He, L., Li, H., Huang, N., Zhou, X., Tian, J., Li, T., Wu, J., Tian, Y., Yin, Y., & Kang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16875 · Cited by 52
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Biagioli, M., & Carino, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_225 · Cited by 56
Effect of gut flora mediated‐bile acid metabolism on intestinal immune microenvironment
Zhang, Y., Gao, X., Gao, S., Liu, Y., Wang, W., Feng, Y., Pei, L., Sun, Z., Liu, L., & Wang, C. (2023) · Immunology · doi:10.1111/imm.13672 · Cited by 53
Retinoid X Receptor Antagonists
Watanabe, M., & Kakuta, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082354 · Cited by 51
Fei, J., Fu, L., Hu, B., Chen, Y., Zhao, H., Xu, D., & Li, J. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.005 · Cited by 51
Shaik, F. B., Panati, K., Narasimha, V. R., & Narala, V. R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.104 · Cited by 50
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Zhou, M., Wang, D., Li, X., Cao, Y., Yi, C., Ocansey, D. K. W., Zhou, Y., & Mao, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016836 · Cited by 56
Fiorucci, S., Mencarelli, A., Cipriani, S., Renga, B., Palladino, G., Santucci, L., & Distrutti, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01481.x · Cited by 53
Self-citationNuclear receptors and chromatin: an inducible couple
Gadaleta, R. M., & Magnani, L. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0170 · Cited by 60
González-Sanmiguel, J., Schuh, C. M. A. P., Muñoz-Montesino, C., Contreras‐Kallens, P., Aguayo, L. G., & Aguayo, S. D. (2020) · Cells · doi:10.3390/cells9112476 · Cited by 50
Lian, F., Xing, X., Yuan, G., Schäfer, C., Rauser, S., Walch, A. K., Röcken, C., Ebeling, M., Wright, M. B., Schmid, R. M., et al. (2011) · Biochemical Journal · doi:10.1042/bj20102096 · Cited by 49
The gut-brain axis in ischemic stroke: its relevance in pathology and as a therapeutic target
Benakis, C., & Liesz, A. (2022) · Neurological Research and Practice · doi:10.1186/s42466-022-00222-8 · Cited by 60
Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols
Tveter, K. M., Mezhibovsky, E., Wu, Y., & Roopchand, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108457 · Cited by 53
Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
Almeqdadi, M., & Gordon, F. D. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.013 · Cited by 55
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review
Sosnowski, K., & Przybyłkowski, A. M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393272 · Cited by 58
Herrera-Uribe, J., Collado-Romero, M., Zaldívar‐López, S., Arce, C., Bautista, R., Carvajal, A., Cirera, S., Claros, M. G., & Garrido, J. J. (2016) · Veterinary Research · doi:10.1186/s13567-015-0286-9 · Cited by 55
Nuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45
Zhang, L., Miao, C., Wang, Z., Guan, X., Ma, Y., Song, J., Shen, S., Song, H., Li, M., & Liu, C. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155416 · Cited by 47
You, W., Li, L., Sun, D., Liu, X., Xia, Z., Xue, S., Chen, B., Qin, H., Ai, J., & Jiang, H. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0672 · Cited by 48
Zhang, R., Liu, L., Wang, X.-W., Guo, C.-J., & Zhu, H. (2019) · Aquaculture · doi:10.1016/j.aquaculture.2019.734636 · Cited by 45
Dong, X., Qi, M., Cai, C., Zhu, Y., Li, Y., Coulter, S., Sun, F., Liddle, C., Uboha, N. V., Halberg, R. B., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170428 · Cited by 51
Li, W., Chen, H., & Tang, J. (2024) · Pathogens · doi:10.3390/pathogens13080702 · Cited by 53
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions
Varricchi, G., Poto, R., Ianiro, G., Punziano, A., Marone, G., Gasbarrini, A., & Spadaro, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712915 · Cited by 49
FXR activation inhibits inflammation and preserves the intestinal barrier in IBD
Wildenberg, M. E., & van den Brink, G. R. (2011) · Gut · doi:10.1136/gut.2010.233304 · Cited by 43
Nuclear receptors, cholesterol homeostasis and the immune system
Shahoei, S. H., & Nelson, E. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.013 · Cited by 43
Review of the Relationships Between Human Gut Microbiome, Diet, and Obesity
Patloka, O., Komprda, T., & Franke, G. (2024) · Nutrients · doi:10.3390/nu16233996 · Cited by 55
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
Makri, E. S., Cholongitas, Ε., & Τζιόμαλος, Κ. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9039 · Cited by 45
FXR Protects Lung from Lipopolysaccharide-Induced Acute Injury
Zhang, L., Li, T., Yu, D. D., FORMAN, B. M., & Huang, W. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0042 · Cited by 44
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
Cunha, T. D., Vaziri, H., & Wu, G. Y. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00344 · Cited by 49
The Role of Bile Acids in the Human Body and in the Development of Diseases
Shulpekova, Y. O., Жаркова, М. С., Tkachenko, P. E., Тихонов, И. Н., Stepanov, A. A., Sinitsyna, A. A., Izotov, A., Butkova, T. V., Shulpekova, N. V., Лапина, Н. В., et al. (2022) · Molecules · doi:10.3390/molecules27113401 · Cited by 49
Microbiome modulates intestinal homeostasis against inflammatory diseases
Sun, X., & Jia, Z. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.10.014 · Cited by 48
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 46
Zhang, Z., Zhou, H., Zhou, X., Sun, J., Liang, X., Lv, Y., Bai, L., Zhang, J., Gong, P., Liu, T., et al. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003001 · Cited by 42
Microbial metabolites are involved in tumorigenesis and development by regulating immune responses
Liu, J., Tian, R., Sun, C., Guo, Y., Dong, L., Li, Y., & Song, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1290414 · Cited by 41
Du, J., Xiang, X., Li, Y., Ji, R., Xu, H., Mai, K., & Ai, Q. (2017) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2017.09.007 · Cited by 44
Gong, Y., Li, K., Qin, Y., Zeng, K., Liu, J., Huang, S., Chen, Y., Yu, H., Liu, W., Ye, L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.711448 · Cited by 41
Steroidal Scaffolds as FXR and GPBAR1 Ligands: From Chemistry to Therapeutical Application
Sepe, V., Distrutti, E., Limongelli, V., Fiorucci, S., & Zampella, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.54 · Cited by 37
Self-citationPost-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
Appelman, M. D., van der Veen, S. W., & van Mil, S. W. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.729828 · Cited by 41
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion
Hucke, S., Herold, M. V. B., Liebmann, M., Freise, N., Lindner, M., Fleck, A.-K., Zenker, S., Thiebes, S., Fernández‐Orth, J., Buck, D., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1593-6 · Cited by 40
Wang, Y., Jia, X., & Cong, B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1396031 · Cited by 50
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders
Fiorucci, S., Urbani, G., Distrutti, E., & Biagioli, M. (2025) · Pharmaceuticals · doi:10.3390/ph18091424 · Cited by 47
Self-citationNuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins
Balasubramaniyan, N., Ananthanarayanan, M., & Suchy, F. J. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00363.2015 · Cited by 38
Gao, R. Y., Shearn, C. T., Orlicky, D. J., Battista, K. D., Alexeev, E. E., Cartwright, I. M., Lanis, J. M., Kostelecky, R. E., Ju, C., Colgan, S. P., et al. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00347-6 · Cited by 37
Barone, I., Vircillo, V., Giordano, C., Gelsomino, L., Győrffy, B., Tarallo, R., Rinaldi, A., Bruno, G., Caruso, A., Romeo, F., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.026 · Cited by 38
Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
Miyazaki, T., Shirakami, Y., Mizutani, T., Maruta, A., Ideta, T., Kubota, M., Sakai, H., Ibuka, T., Genovese, S., Fiorito, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79916-5 · Cited by 40
Runge, S., & Rosshart, S. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702378 · Cited by 41
Guo, S., Peng, Y., Lou, Y., Cao, L., Liu, J., Lin, N., Cai, S., Kang, Y., Zeng, S., & Yu, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106101 · Cited by 40
Bile Acids and the Potential Role in Primary Biliary Cirrhosis
Yang, H., & Duan, Z. (2016) · Digestion · doi:10.1159/000452300 · Cited by 35
Zhu, P., Zhang, J., Chen, Y., Yin, S., Su, M., Xie, G., Brouwer, K. L. R., Liu, C., Lan, K., & Jia, W. P. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1183-7 · Cited by 37
Regulation of mononuclear phagocyte function by the microbiota at mucosal sites
Scott, N. A., & Mann, E. R. (2019) · Immunology · doi:10.1111/imm.13155 · Cited by 37
Jin, D., Lu, T., Ni, M., Wang, H., Zhang, J., Zhong, C., Shen, C., Hao, J., Busuttil, R. W., Kupiec‐Weglinski, J. W., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1478 · Cited by 36
Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease
Yan, P., & Li, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000718 · Cited by 36
Bacterial metabolites directly modulate farnesoid X receptor activity
Zhang, X., Osaka, T., & Tsuneda, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0045-y · Cited by 34
The influence of microbiota-derived metabolites on viral infections
Alwin, A., & Karst, S. M. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.05.006 · Cited by 37
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis
Bernardi, F., D’Amico, F., Bencardino, S., Faggiani, I., Fanizza, J., Zilli, A., Parigi, T. L., Allocca, M., Danese, S., & Furfaro, F. (2024) · Pharmaceuticals · doi:10.3390/ph17030347 · Cited by 41
McMillan, A. S., & Theriot, C. M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393766 · Cited by 44
Lv, B., Ma, L., Tang, W., Huang, P., Yang, B., Wang, L., Chen, S., Gao, Q., Zhang, S., & Xia, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491715 · Cited by 34
A perspective of intestinal immune-microbiome interactions in alcohol-associated Liver Disease
Bruellman, R., & Llorente, C. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53589 · Cited by 38
Diarrhea in Crohn’s Disease: Investigating the Role of the Ileal Hormone Fibroblast Growth Factor 19
Nolan, J., Johnston, I. M., Pattni, S. S., Dew, T. K., Orchard, T. R., & Walters, J. R. F. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju022 · Cited by 38
Sun, X., Chen, Z., Yu, L., Zeng, W., Sun, B., Fan, H., & Bai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205323 · Cited by 33
“FXR is implicated in intestinal immunomodulation and barrier function (Vavassori et al., 2009).”
Background
Metadata
- Authors
- Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Azienda Ospedaliera di Perugia (IT)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6251-6261
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125524268
- Cited by
- 655
- References
- 34
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 49 · 2023: 52 · 2022: 71 · 2021: 56 · 2020: 55 · 2019: 40 · 2018: 34 · 2017: 36 · 2016: 31 · 2015: 31 · 2014: 25 · 2013: 22 · 2012: 25
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- farnesoid X receptor, intestinal innate immunity, colitis, Crohn's disease, NF-κB, SHP, NCoR, macrophages, chenodeoxycholic acid, trinitrobenzene sulfonic acid, dextran sulfate, TNF-α, IL-1β, interleukin-6, intestinal inflammation, nuclear receptors, intestinal homeostasis
- MeSH terms
- Receptor, Farnesoid X-Activated, Acute Disease, Adult, Animals, Chronic Disease, Colitis, Crohn Disease, Female, Humans, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Trinitrobenzenesulfonic Acid, NF-kappa B, Mice, SCID, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.